205 related articles for article (PubMed ID: 27979043)
1. Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study.
Zettler ME; Peterson ED; McCoy LA; Effron MB; Anstrom KJ; Henry TD; Baker BA; Messenger JC; Cohen DJ; Wang TY;
Am Heart J; 2017 Jan; 183():62-68. PubMed ID: 27979043
[TBL] [Abstract][Full Text] [Related]
2. In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.
Bagai A; Peterson ED; Honeycutt E; Effron MB; Cohen DJ; Goodman SG; Anstrom KJ; Gupta A; Messenger JC; Wang TY
Eur Heart J Acute Cardiovasc Care; 2015 Dec; 4(6):499-508. PubMed ID: 25515725
[TBL] [Abstract][Full Text] [Related]
3. Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome).
Fosbøl EL; Ju C; Anstrom KJ; Zettler ME; Messenger JC; Waksman R; Effron MB; Baker BA; Cohen DJ; Peterson ED; Wang TY
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27789517
[TBL] [Abstract][Full Text] [Related]
4. Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT).
Déry JP; Mehta SR; Fisher HN; Zhang X; Zhu YE; Welsh RC; Lavi S; Cieza T; Henderson MA; Lutchmedial S; Siega AJ; Cheema AN; Wong BY; Kokis A; Dehghani P; Goodman SG;
Am Heart J; 2016 Nov; 181():26-34. PubMed ID: 27823690
[TBL] [Abstract][Full Text] [Related]
5. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
[TBL] [Abstract][Full Text] [Related]
6. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
Bagai A; Wang Y; Wang TY; Curtis JP; Gurm HS; Shah B; Cheema AN; Peterson ED; Saucedo JF; Granger CB; Roe MT; Bhatt DL; McNamara RL; Alexander KP
Circ Cardiovasc Interv; 2014 Aug; 7(4):585-93. PubMed ID: 25097196
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy.
Bagai A; Wang TY; Goodman SG; Fisher HN; Welsh RC; Dery JP; Zhang X; Zhu YE; Cheema AN; Dehghani P; Kassam SA; Ducas J; Brass N; Kim HH; Fung A; Schampaert E; Quraishi AU; Mehta SR;
Int J Cardiol; 2017 Feb; 228():459-464. PubMed ID: 27870977
[TBL] [Abstract][Full Text] [Related]
8. Association of measured platelet reactivity with changes in P2Y
Bagai A; Peterson ED; McCoy LA; Effron MB; Zettler ME; Stone GW; Henry TD; Cohen DJ; Schulte PJ; Anstrom KJ; Wang TY
Am Heart J; 2017 May; 187():19-28. PubMed ID: 28454802
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
[TBL] [Abstract][Full Text] [Related]
10. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.
Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P;
Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465
[TBL] [Abstract][Full Text] [Related]
11. The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
Effron MB; Wang TY; Fonarow GC; Henry TD; Zettler ME; Baker BA; McCoy LA; Peterson ED
Catheter Cardiovasc Interv; 2018 Feb; 91(2):242-250. PubMed ID: 28988425
[TBL] [Abstract][Full Text] [Related]
12. 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.
Motovska Z; Hlinomaz O; Kala P; Hromadka M; Knot J; Varvarovsky I; Dusek J; Jarkovsky J; Miklik R; Rokyta R; Tousek F; Kramarikova P; Svoboda M; Majtan B; Simek S; Branny M; Mrozek J; Cervinka P; Ostransky J; Widimsky P;
J Am Coll Cardiol; 2018 Jan; 71(4):371-381. PubMed ID: 29154813
[TBL] [Abstract][Full Text] [Related]
13. Comparative Efficacy and Safety of Prasugrel, Ticagrelor, and Standard-Dose and High-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis.
Singh S; Singh M; Grewal N; Khosla S
Am J Ther; 2016; 23(1):e52-62. PubMed ID: 26448337
[TBL] [Abstract][Full Text] [Related]
14. A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.
Westman PC; Lipinski MJ; Torguson R; Waksman R
Cardiovasc Revasc Med; 2017 Mar; 18(2):79-85. PubMed ID: 28089137
[TBL] [Abstract][Full Text] [Related]
15. One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.
Effron MB; Nair KV; Molife C; Keller SY; Page RL; Simeone JC; Murphy B; Nordstrom BL; Zhu Y; McCollam PL; Vetrovec GW
Am J Cardiovasc Drugs; 2018 Apr; 18(2):129-141. PubMed ID: 29222628
[TBL] [Abstract][Full Text] [Related]
16. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
17. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.
Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR
Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494
[TBL] [Abstract][Full Text] [Related]
18. "Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.
Larmore C; Effron MB; Molife C; DeKoven M; Zhu Y; Lu J; Karkare S; Lieu HD; Lee WC; Vetrovec GW
Catheter Cardiovasc Interv; 2016 Oct; 88(4):535-544. PubMed ID: 26577386
[TBL] [Abstract][Full Text] [Related]
19. Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study.
Wang TY; Henry TD; Effron MB; Honeycutt E; Hess CN; Zettler ME; Cohen DJ; Baker BA; Berger PB; Anstrom KJ; Angiolillo DJ; Peterson ED;
Circ Cardiovasc Interv; 2015 Jun; 8(6):e001712. PubMed ID: 26025216
[TBL] [Abstract][Full Text] [Related]
20. Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview.
Verdoia M; Barbieri L; Suryapranata H; De Luca G
Platelets; 2016; 27(2):93-104. PubMed ID: 25970631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
